A Bivalent Recombinant Mycobacterium bovis BCG Expressing the S1 Subunit of the Pertussis Toxin Induces a Polyfunctional CD4+ T Cell Immune Response
Background. A recombinant BCG strain expressing the genetically detoxified S1 subunit of pertussis toxin 9K/129G (rBCG-S1PT), previously constructed by our research group, demonstrated the ability to develop high protection in mouse models of pertussis challenge which correlated with the induction o...
Main Authors: | Alex I. Kanno, Cibelly Goulart, Luciana C. C. Leite, Ana C. Pagliarone, Ivan P. Nascimento |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/9630793 |
Similar Items
-
Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model
by: Ramos Kátia L, et al.
Published: (2008-11-01) -
Vaccination-related Mycobacterium bovis BCG Infection
by: Anna Liberek, et al.
Published: (2006-05-01) -
Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults
by: Piotr Szpakowski, et al.
Published: (2015-01-01) -
Disseminated Mycobacterium bovis Infection after BCG Vaccination
by: Shahla Afshar Paiman, et al.
Published: (2006-09-01) -
Mechanisms of cell accumulation induced by Mycobacterium bovis BCG
by: Octávio Menezes-de-Lima-Júnior, et al.
Published: (1997-12-01)